EU Regulation in a G20 World

The EU, as a major beneficiary of OTC derivatives business, has taken on board the commitments and recommendations agreed in global fora regarding reform of these markets. The global stance taken by the G20, together with the standards being developed through CPSS-IOSCO, translate into a wide-ranging programme of European regulatory reform, deeply affecting OTC derivatives and financial markets more generally.[...]